Combination Therapy Using Non-ablative Fractional Laser and Intralesional Triamcinolone Injection for Hypertrophic Scars and Keloids Treatment

Overview

Journal Int Wound J

Specialties Emergency Medicine
Orthopedics

Date 2019 Sep 3

PMID 31475470

Citations 8

Authors

Jongweon Shin

Jin Tae Cho

Song I Park

Sung No Jung

Affiliations

Soon will be listed here.

Abstract

Combinations of various treatment modalities were shown to be more effective than monotherapy when treating hypertrophic scars and keloids. This study was conducted to assess the effectiveness of combination therapy with non-ablative fractional laser and intralesional steroid injection. From May 2015 to June 2017, a total of 38 patients with hypertrophic scars or keloids were evaluated. The control group of 21 patients received steroid injection alone, and 17 patients (the combined group) received 1550-nm erbium-glass fractional laser treatment and steroid injection simultaneously. The mean number of treatment sessions was statistically fewer in the combined group than in the control group (6.95 vs 5.47, P = .042). There was a significant difference in the patient's scale in the combined group (14.62 vs 22.82, P = .005); however, the observer's scale was not significantly different (17.92 vs 20.55, P = .549). The recurrence rate was 38.1% (8/21) in the control group and 35.3% (6/17) in the combined groups and showed no significant difference (P = .859). However, the mean remission period was statistically longer in the combined group (3.00 months vs 4.17 months, P = .042). Combination therapy with non-ablative fractional laser and intralesional steroid injection showed better results for the treatment of hypertrophic scars and keloids with fewer treatment sessions, better patient satisfaction, and longer remission periods.

Citing Articles

Evaluating the effectiveness and safety of pulsed dye laser alone, the combination of pulsed dye laser and botulinum toxin type A, and the combination of pulsed dye laser and triamcinolone injection in the treatment of hypertrophic and keloid scars:....

Atefi N, Jafari M, Roohaninasab M, Dehghani A, Jafarzadeh A, Peighambari S Lasers Med Sci. 2025; 40(1):92.

PMID: 39953344 DOI: 10.1007/s10103-025-04338-6.

Efficacy of Nd:YAG Laser and Intralesional Triamcinolone Injection Combination Therapy in the Postoperative Management of Keloids.

Park J, Jeong J, Park J Aesthetic Plast Surg. 2024; 49(2):576-583.

PMID: 39373734 PMC: 11814004. DOI: 10.1007/s00266-024-04433-z.

The efficacy, satisfaction, and safety of carbon dioxide (CO2) fractional laser in combination with pulsed dye laser (PDL) versus each one alone in the treatment of hypertrophic burn scars: a single-blinded randomized controlled trial.

Kivi M, Jafarzadeh A, Hosseini-Baharanchi F, Salehi S, Goodarzi A Lasers Med Sci. 2024; 39(1):69.

PMID: 38376542 DOI: 10.1007/s10103-024-03976-6.

Efficacy of fractional CO laser in combination with stromal vascular fraction (SVF) compared with fractional CO laser alone in the treatment of burn scars: a randomized controlled clinical trial.

Roohaninasab M, Khodadad F, Sadeghzadeh-Bazargan A, Atefi N, Zare S, Jafarzadeh A Stem Cell Res Ther. 2023; 14(1):269.

PMID: 37742019 PMC: 10518108. DOI: 10.1186/s13287-023-03480-8.

Advances in Photoelectric Therapy for the Early Intervention and Treatment of Traumatic Scars.

Tian Q, Zhang Y, Wang J, Huang G Clin Cosmet Investig Dermatol. 2023; 16:869-877.

PMID: 37038450 PMC: 10082596. DOI: 10.2147/CCID.S407361.

References

Roberts W . Skin type classification systems old and new. Dermatol Clin. 2009; 27(4):529-33, viii. DOI: 10.1016/j.det.2009.08.006. View

Ryu H, Cho J, Lee K, Cho J . Prevention of thyroidectomy scars in Korean patients using a new combination of intralesional injection of low-dose steroid and pulsed dye laser starting within 4 weeks of suture removal. Dermatol Surg. 2014; 40(5):562-8. DOI: 10.1111/dsu.12472. View

Niwa A, Mello A, Torezan L, Osorio N . Fractional photothermolysis for the treatment of hypertrophic scars: clinical experience of eight cases. Dermatol Surg. 2009; 35(5):773-7. DOI: 10.1111/j.1524-4725.2009.01127.x. View

Behera B, Kumari R, Thappa D, Malathi M . Therapeutic Efficacy of Intralesional Steroid With Carbon Dioxide Laser Versus With Cryotherapy in Treatment of Keloids: A Randomized Controlled Trial. Dermatol Surg. 2016; 42(10):1188-98. DOI: 10.1097/DSS.0000000000000873. View

Sachdeva S . Nonablative fractional laser resurfacing in Asian skin--a review. J Cosmet Dermatol. 2010; 9(4):307-12. DOI: 10.1111/j.1473-2165.2010.00528.x. View

Yagmur C, Akaishi S, Ogawa R, Guneren E . Mechanical receptor-related mechanisms in scar management: a review and hypothesis. Plast Reconstr Surg. 2010; 126(2):426-434. DOI: 10.1097/PRS.0b013e3181df715d. View

Lin J, Warger W, Izikson L, Anderson R, Tannous Z . A prospective, randomized controlled trial on the efficacy of fractional photothermolysis on scar remodeling. Lasers Surg Med. 2011; 43(4):265-72. DOI: 10.1002/lsm.21061. View

Tidwell W, Green C, Jensen D, Ross E . Clinical evaluation and in-vivo analysis of the performance of a fractional infrared 1550 nm laser system for skin rejuvenation. J Cosmet Laser Ther. 2018; 20(6):360-363. DOI: 10.1080/14764172.2018.1511915. View

Cho S, Jung J, Shin J, Lee J . Non-ablative 1550 nm erbium-glass and ablative 10,600 nm carbon dioxide fractional lasers for various types of scars in Asian people: evaluation of 100 patients. Photomed Laser Surg. 2013; 32(1):42-6. DOI: 10.1089/pho.2013.3608. View

10.

Kunishige J, Katz T, Goldberg L, Friedman P . Fractional photothermolysis for the treatment of surgical scars. Dermatol Surg. 2010; 36(4):538-41. DOI: 10.1111/j.1524-4725.2010.01491.x. View

11.

Shin J, Gantsetseg D, Jung J, Jung I, Shin S, Lee J . Comparison of non-ablative and ablative fractional laser treatments in a postoperative scar study. Lasers Surg Med. 2014; 46(10):741-9. DOI: 10.1002/lsm.22297. View

12.

Choe J, Park Y, Kim B, Kim M, Rho N, Park B . Prevention of thyroidectomy scar using a new 1,550-nm fractional erbium-glass laser. Dermatol Surg. 2009; 35(8):1199-205. DOI: 10.1111/j.1524-4725.2008.34428.x. View

13.

Jang J, Kim S, Yoon E, Kim W, Park S, Lee B . Comparison of the Effectiveness of Ablative and Non-Ablative Fractional Laser Treatments for Early Stage Thyroidectomy Scars. Arch Plast Surg. 2016; 43(6):575-581. PMC: 5122549. DOI: 10.5999/aps.2016.43.6.575. View

14.

Kim H, Kim T, Kwon Y, Park J, Lee J . Comparison of a 1,550 nm Erbium: glass fractional laser and a chemical reconstruction of skin scars (CROSS) method in the treatment of acne scars: a simultaneous split-face trial. Lasers Surg Med. 2009; 41(8):545-9. DOI: 10.1002/lsm.20796. View

15.

Kelly A . Medical and surgical therapies for keloids. Dermatol Ther. 2004; 17(2):212-8. DOI: 10.1111/j.1396-0296.2004.04022.x. View

16.

Haedersdal M, Moreau K, Beyer D, Nymann P, Alsbjorn B . Fractional nonablative 1540 nm laser resurfacing for thermal burn scars: a randomized controlled trial. Lasers Surg Med. 2009; 41(3):189-95. DOI: 10.1002/lsm.20756. View

17.

Cho S, Lee S, Cho S, Oh S, Chung W, Kang J . Non-ablative 1550-nm erbium-glass and ablative 10 600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation. J Eur Acad Dermatol Venereol. 2009; 24(8):921-5. DOI: 10.1111/j.1468-3083.2009.03551.x. View

18.

Ogawa R . Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci. 2017; 18(3). PMC: 5372622. DOI: 10.3390/ijms18030606. View

19.

Shim H, Jun D, Kim S, Jung S, Kwon H . Low versus High Fluence Parameters in the Treatment of Facial Laceration Scars with a 1,550 nm Fractional Erbium-Glass Laser. Biomed Res Int. 2015; 2015:825309. PMC: 4508380. DOI: 10.1155/2015/825309. View

20.

Asilian A, Darougheh A, Shariati F . New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006; 32(7):907-15. DOI: 10.1111/j.1524-4725.2006.32195.x. View